4.
Question 4
Which of the following are described as the key objectives of a Phase I trial, regardless of drug?
1 point
assess appropriateness of stopping rules
determine inclusion/exclusion recommendations
characterize the pharmacokinetic (PK) profile
assess safety and tolerability